Liver Cancer Therapeutics Market - Top Companies and Manufacturers

Companies Dominating the Liver Cancer Therapeutics Landscape

Bristol-Myers Squibb Company
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Eisai Co., Ltd.
Exelixis, Inc.
Merck Sharp & Dohme Corp. (Merck & Co., Inc.)
Bayer AG
Zymeworks Inc.
F. Hoffmann-La Roche Ltd.
Celsion Corporation
Eli Lilly and Company
AstraZeneca

Browse Key Market Insights with Data Illustration:

Liver Cancer Therapeutics Market Size - Growth Trends 2036

In the News

June 2019: Exelixis, Inc. announced that CABOMETYX tablets have been approved by the U.S. Food and Drug Administration (FDA) for patients with hepatocellular carcinoma (HCC), previously treated with sorafenib.
May 2019: Eli Lilly and Company announced that their CYRAMZA has become the first U.S. FDA-approved biomarker-driven therapy for the second-line treatment of patients with hepatocellular carcinoma (HCC). This approval has been noted as an important step forward in the treatment of advanced hepatocellular carcinoma.

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of liver cancer therapeutics is estimated at USD 3.43 billion.

Liver Cancer Therapeutics Market size was over USD 2.99 billion in 2023 and is anticipated to reach USD 26.87 billion by 2036, witnessing around 18.4% CAGR during the forecast period i.e., between 2024-2036. Growing prevalence of liver cancer, rise in incidence of hepatitis B infection in developing countries, and increasing R&D activities and advancement in cancer therapeutics will impel the market growth.

North America region is expected to hold largest industry share by 2036, owing to high awareness about liver cancer, presence of well-established healthcare infrastructure, and easy drug availability.

The major players in the market are Bristol-Myers Squibb Company, Eisai Co., Ltd., Exelixis, Inc., Merck Sharp & Dohme Corp. (Merck & Co., Inc.), Bayer AG, Zymeworks Inc., F. Hoffmann-La Roche Ltd., Celsion Corporation, Eli Lilly and Company, AstraZeneca, and others.

Liver Cancer Therapeutics Market - Top Companies and Manufacturers

Companies Dominating the Liver Cancer Therapeutics Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What is the size of the liver cancer therapeutics market?

Why is the liver cancer therapeutics sector gaining traction in near future?

Which region accounted for the largest liver cancer therapeutics industry share?

Who are the major liver cancer therapeutics players?